JP7437395B2 - 細胞傷害性ベンゾジアゼピン誘導体の調製方法 - Google Patents

細胞傷害性ベンゾジアゼピン誘導体の調製方法 Download PDF

Info

Publication number
JP7437395B2
JP7437395B2 JP2021524303A JP2021524303A JP7437395B2 JP 7437395 B2 JP7437395 B2 JP 7437395B2 JP 2021524303 A JP2021524303 A JP 2021524303A JP 2021524303 A JP2021524303 A JP 2021524303A JP 7437395 B2 JP7437395 B2 JP 7437395B2
Authority
JP
Japan
Prior art keywords
formula
compound
iia
reaction
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021524303A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512935A (ja
JP2022512935A5 (cg-RX-API-DMAC10.html
Inventor
リアドン，マイケル
シルバ，リチャード・エイ
Original Assignee
イミュノジェン・インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by イミュノジェン・インコーポレーテッド filed Critical イミュノジェン・インコーポレーテッド
Publication of JP2022512935A publication Critical patent/JP2022512935A/ja
Publication of JP2022512935A5 publication Critical patent/JP2022512935A5/ja
Priority to JP2024018294A priority Critical patent/JP2024056819A/ja
Application granted granted Critical
Publication of JP7437395B2 publication Critical patent/JP7437395B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C233/07—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/22—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of hydropolysulfides or polysulfides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/20—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2021524303A 2018-11-12 2019-11-11 細胞傷害性ベンゾジアゼピン誘導体の調製方法 Active JP7437395B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024018294A JP2024056819A (ja) 2018-11-12 2024-02-09 細胞傷害性ベンゾジアゼピン誘導体の調製方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862758814P 2018-11-12 2018-11-12
US62/758,814 2018-11-12
PCT/US2019/060677 WO2020102051A1 (en) 2018-11-12 2019-11-11 Methods of preparing cytotoxic benzodiazepine derivatives

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024018294A Division JP2024056819A (ja) 2018-11-12 2024-02-09 細胞傷害性ベンゾジアゼピン誘導体の調製方法

Publications (3)

Publication Number Publication Date
JP2022512935A JP2022512935A (ja) 2022-02-07
JP2022512935A5 JP2022512935A5 (cg-RX-API-DMAC10.html) 2022-11-17
JP7437395B2 true JP7437395B2 (ja) 2024-02-22

Family

ID=68835289

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021524303A Active JP7437395B2 (ja) 2018-11-12 2019-11-11 細胞傷害性ベンゾジアゼピン誘導体の調製方法
JP2024018294A Withdrawn JP2024056819A (ja) 2018-11-12 2024-02-09 細胞傷害性ベンゾジアゼピン誘導体の調製方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024018294A Withdrawn JP2024056819A (ja) 2018-11-12 2024-02-09 細胞傷害性ベンゾジアゼピン誘導体の調製方法

Country Status (12)

Country Link
US (3) US10851117B2 (cg-RX-API-DMAC10.html)
EP (2) EP3880681B1 (cg-RX-API-DMAC10.html)
JP (2) JP7437395B2 (cg-RX-API-DMAC10.html)
KR (1) KR20210098470A (cg-RX-API-DMAC10.html)
CN (2) CN112996792B (cg-RX-API-DMAC10.html)
AU (1) AU2019379104A1 (cg-RX-API-DMAC10.html)
CA (1) CA3119358A1 (cg-RX-API-DMAC10.html)
IL (1) IL283045A (cg-RX-API-DMAC10.html)
MA (1) MA54228A (cg-RX-API-DMAC10.html)
SG (1) SG11202104360YA (cg-RX-API-DMAC10.html)
TW (1) TW202033530A (cg-RX-API-DMAC10.html)
WO (1) WO2020102051A1 (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3612533A1 (en) * 2017-04-20 2020-02-26 Immunogen, Inc. Methods of preparing indolinobenzodiazepine derivatives
CN112996792B (zh) 2018-11-12 2024-04-26 伊缪诺金公司 制备细胞毒性苯并二氮杂卓衍生物的方法
AU2023298568A1 (en) 2022-06-30 2025-01-09 Toray Industries, Inc. Pharmaceutical composition for cancer treatment and/or prevention

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017004026A1 (en) 2015-06-29 2017-01-05 Immunogen, Inc. Anti-cd 123 antibodies and conjugates and derivatives thereof
WO2017004025A1 (en) 2015-06-29 2017-01-05 Immunogen, Inc. Conjugates of cysteine engineered antibodies
WO2017015496A1 (en) 2015-07-21 2017-01-26 Immunogen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives
WO2017091745A1 (en) 2015-11-25 2017-06-01 Immunogen, Inc. Pharmaceutical formulations and methods of use thereof
WO2018140435A1 (en) 2017-01-25 2018-08-02 Immunogen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives
WO2019133652A1 (en) 2017-12-28 2019-07-04 Immunogen, Inc. Benzodiazepine derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902707A (en) * 1985-04-30 1990-02-20 Eli Lilly And Company Bicyclic pyrazolidinones, compositions and use
US5015738A (en) * 1989-08-07 1991-05-14 Hoechst-Roussel Pharmaceuticals Inc. Benzo(b)pyrrolobenzodiazepines
CN102050824A (zh) * 2009-11-04 2011-05-11 上海阳帆医药科技有限公司 哌嗪并三唑衍生物
SI2675480T1 (sl) 2011-02-15 2019-05-31 Immunogen, Inc. Metode priprave konjugatov
RU2539658C1 (ru) 2013-12-10 2015-01-20 Федеральное государственное казенное учреждение "33 Центральный научно-исследовательский испытательный институт Министерства обороны Российской Федерации" Способ получения бензилхлорида
CN112996792B (zh) 2018-11-12 2024-04-26 伊缪诺金公司 制备细胞毒性苯并二氮杂卓衍生物的方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017004026A1 (en) 2015-06-29 2017-01-05 Immunogen, Inc. Anti-cd 123 antibodies and conjugates and derivatives thereof
WO2017004025A1 (en) 2015-06-29 2017-01-05 Immunogen, Inc. Conjugates of cysteine engineered antibodies
WO2017015496A1 (en) 2015-07-21 2017-01-26 Immunogen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives
WO2017091745A1 (en) 2015-11-25 2017-06-01 Immunogen, Inc. Pharmaceutical formulations and methods of use thereof
WO2018140435A1 (en) 2017-01-25 2018-08-02 Immunogen, Inc. Methods of preparing cytotoxic benzodiazepine derivatives
WO2019133652A1 (en) 2017-12-28 2019-07-04 Immunogen, Inc. Benzodiazepine derivatives

Also Published As

Publication number Publication date
IL283045A (en) 2021-06-30
SG11202104360YA (en) 2021-05-28
EP4361128A2 (en) 2024-05-01
US10851117B2 (en) 2020-12-01
MA54228A (fr) 2021-09-22
WO2020102051A8 (en) 2020-06-18
JP2022512935A (ja) 2022-02-07
TW202033530A (zh) 2020-09-16
CN118324848A (zh) 2024-07-12
KR20210098470A (ko) 2021-08-10
WO2020102051A1 (en) 2020-05-22
EP3880681B1 (en) 2024-03-13
US20200172555A1 (en) 2020-06-04
CN112996792A (zh) 2021-06-18
US20210122768A1 (en) 2021-04-29
CA3119358A1 (en) 2020-05-22
US20230045079A1 (en) 2023-02-09
US11981688B2 (en) 2024-05-14
EP4361128A3 (en) 2024-07-17
CN112996792B (zh) 2024-04-26
US11396519B2 (en) 2022-07-26
JP2024056819A (ja) 2024-04-23
EP3880681A1 (en) 2021-09-22
AU2019379104A1 (en) 2021-06-03

Similar Documents

Publication Publication Date Title
JP2024056819A (ja) 細胞傷害性ベンゾジアゼピン誘導体の調製方法
US10392407B2 (en) Methods of preparing cytotoxic benzodiazepine derivatives
JP7400005B2 (ja) 細胞傷害性ベンゾジアゼピン誘導体の調製方法
EP3704097B1 (en) Bicyclic sulfones and sulfoxides and methods of use thereof
RU2813137C2 (ru) Способы получения цитотоксических производных бензодиазепина
CN117836288A (zh) 调节ikzf2的芳基化合物和医药组合物
Hollá Synthesis of polycyclic lactones and lactams
CN103965198A (zh) 替卡格雷的中间体及其制备方法以及利用该中间体制备替卡格雷的方法
HK40018558B (en) Methods of preparing cytotoxic benzodiazepine derivatives
HK40018558A (en) Methods of preparing cytotoxic benzodiazepine derivatives

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221109

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20221109

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230911

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20231211

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20240111

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20240209

R150 Certificate of patent or registration of utility model

Ref document number: 7437395

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150